BDBM536315 (E)-3-(4-((4-ethoxy-3-(6-((hydroxyimino)methyl)-5-methyl-4-oxo-7-propyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazin-2-yl)phenyl)sulfonyl)piperazin-1-yl)propyl nitrate::US11242347, Compound 1ao::US11897890, Compound lao

SMILES CCCc1c(/C=N/O)c(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CCCO[N+](=O)[O-])CC4)ccc3OCC)nn12

InChI Key InChIKey=FLXBJQAVYRDWDU-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 536315   

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 536315BDBM536315((E)-3-(4-((4-ethoxy-3-(6-((hydroxyimino)methyl)-5-...)
Affinity DataIC50: 12nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 536315BDBM536315((E)-3-(4-((4-ethoxy-3-(6-((hydroxyimino)methyl)-5-...)
Affinity DataIC50: 12nMAssay Description:Experimental protocol: The test compound, i.e the compound of the present invention, reference compound or water (control) are added to a buffer cont...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
US Patent

TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Topadur Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 536315BDBM536315((E)-3-(4-((4-ethoxy-3-(6-((hydroxyimino)methyl)-5-...)
Affinity DataIC50: 12nMAssay Description:Purpose: Evaluation of the effects of compounds of the present invention on the activity of the human phosphodiesterase-5 quantified by measuring the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent